Joana Goncalves sold $651K of Oruka Therapeutics (ORKA)

Executed Aug 17, disclosed Aug 17, the same day.

Value, as filed

$651K

5,800 sh across 2 lots

Executed

Aug 17

the trade date, as filed

Disclosed

Aug 17

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Joana Goncalves Chief Medical Officer profile →

Joana Goncalves (Chief Medical Officer) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $651K of ORKA (5,800 sh across 2 lots, as filed), executed Aug 17.

The name

ORKA

Oruka Therapeutics, Inc. ORKA · Healthcare · 27 filings in 24 months ticker →

Healthcare · Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psor…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Joana Goncalves in ORKA

ORKASALE Oruka Therapeutics, Inc. $634K
6,900 sh across 3 lots
Exec Sep 15
Filed Sep 15 · 7:18 PM ET ORKASALE Oruka Therapeutics, Inc. $544K
6,300 sh across 2 lots
Exec Jul 15
Filed Jul 15 · 7:36 PM ET ORKASALE Oruka Therapeutics, Inc. $463K
6,700 sh across 2 lots
Exec Jun 15
Filed Jun 15 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. $427K
6,900 sh across 2 lots
Exec May 15
Filed May 15 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. $429K
6,500 sh across 2 lots
Exec Apr 15
Filed Apr 15 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. $237K
5,823 sh across 2 lots
Exec Mar 16
Filed Mar 17 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. $196K
6,064 sh × $32.30
Exec Feb 17
Filed Feb 17 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. $138K
4,381 sh × $31.56
Exec Jan 15
Filed Jan 16 · 5:30 PM ET